Browsing by Author "Castro-Mollo, M"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Publication Retos y avances del cáncer de pulmón de células no pequeñas metastásico EGFR mutado(Universidad Ricardo Palma, Instituto de Investigaciones en Ciencias Biomedicas, Facultad de Medicina Humana, 2024) Castro-Mollo, M; Ruiz, R; Roque, K; Mas, LIntroduction: Tyrosine kinase inhibitors have dramatically changed the clinical outcomes for patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutations. However, there are still challenges in the management of patients with this mutation in a metastatic setting, such as intrinsic and acquired resistance to tyrosine kinase inhibitors. We will discuss the latest advances and new strategies in first-line treatment, osimertinib resistance, and exon 20 mutation treatment. © 2024 Universidad Ricardo Palma, Facultad de Medicina Humana. All rights reserved.